The Digital Future Is Now: The New Era Of Evidence Generation In Clinical Trials

A new normal for evidence generation has arrived. Over the last four years, digital technologies, automation, artificial intelligence, and other innovations have seen increasing success in clinical development and patient care. As a result, sponsors and CROs are breaking through the traditional bottlenecks and barriers associated with trials, dramatically altering and accelerating their pipelines. There’s a real opportunity to disrupt the stubborn 12-year average drug development cycle, but it takes cross-industry collaboration to achieve this.

Learn how top pharmaceutical companies are using novel innovations to drive greater speed, scale, and access in clinical research than ever before in this webinar hosted by Musaddiq Khan, Vice President of DCT Solutions at Medable. Key learnings will include how intelligent automation and eCOA technology are reducing study deployment timelines by 50%, how top global pharmaceutical companies are benefiting from Medable’s platform to enable rapid, more informed decision-making, and how the expanded use of digital measures and biomarkers will continue to benefit patients and increase the quality and depth of real-time data insights.